# Best of UEG Week  -  IBD with Bel Kok

Page: https://stenobird.com/podcast/ueg-podcast-6404464/best-of-ueg-week-ibd-with-bel-kok
Text version: https://stenobird.com/podcast/ueg-podcast-6404464/best-of-ueg-week-ibd-with-bel-kok.md
Podcast: [UEG Podcast](https://stenobird.com/podcast/ueg-podcast-6404464)
Published: 2025-11-04T23:05:00+00:00
Episode link: https://ueg-talks-podcast.podigee.io/61-new-episode
Audio file: https://audio.podigee-cdn.net/2187228-m-fc01c1b3b84f4e07918d224a3eb52d85.mp3?source=feed
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/ueg-podcast-6404464/episodes/best-of-ueg-week-ibd-with-bel-kok
Duration seconds: 1146

## Resource

In this episode of the UEG Podcast, our host Pradeep Mundre, together with IBD expert Klaartje Bel Kok, explore the latest breakthroughs in IBD presented at UEG Week 2025 in Berlin. From long-term IL-23 inhibitor data to novel drugs such as Obefazimod and Tulisokibart, the discussion covers key findings that are reshaping IBD management. Bel dives into new insights on JAK inhibitors in pregnancy, the growing role of ultrasound monitoring in IBD, and the challenge of choice overload in treatment decisions. Tune in for expert reflections on emerging research, collaboration within the IBD community, and the evolving understanding of IBD’s complex aetiology.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/ueg-podcast-6404464/episodes/best-of-ueg-week-ibd-with-bel-kok/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/ueg-podcast-6404464/best-of-ueg-week-ibd-with-bel-kok.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.